fda semaglutide warning november 2025 U.S. finds no evidence yet linking weight-loss drugs to suicidal thoughts FDA issued 25 warning letters

Store lyophilized powder long-term at -20C

Metformin, acarbose, empagliflozin, and exenatide were associated with mild weight loss (less than 3.2% of initial weight)

What makes these treatments revolutionary is their ability to tackle not just the symptoms but the root causes of metabolic imbalances

Acidosis drives the reprogramming of fatty acid metabolism in cancer cells through changes in mitochondrial and histone acetylation

High atomic number (high-Z) nanoparticles, such as gold or platinum-based particles, can locally amplify radiation energy deposition, enhancing tumor-specific cytotoxicity without increasing systemic toxicity [213]